ORIGINAL PAPERS |
|
A.M. Essaian, G.P. Arutyunov, O.G. Melikhov
Prevalence of chronic kidney disease in primary care patients. results of a prospective observational study in 12 regions of Russia
|
6-16 |
|
G.G. Gromova, L.N. Verizhnikova, N.V. Zhbanova, A.V. Stepovaya, I.A. Tyurina
Kidney damage in the newcoronavirus disease COVID-19
|
17-22 |
|
P.N. Kislyy, E.V. Parshina, A.B. Zulkarnaev, A.D. Tolkach, S.S. Mikhailova, R.A. Chernikov, Ya.V. Zarya
Risk factors for development of severe hypocalciemia after paratyreoidectomy for secondary hyperparathyroidisis in dialysis patients
|
23-30 |
|
M.N. Kolomyitseva, M.Z. Gasanov, M.M. Batyushin, O.M. Manukyan, L.I. Rudenko
Peculiarities of vascular remodeling in patients with chronic kidney disease stage 5D: prognostic role of the intima-media thickness
|
31-37 |
|
M.A. Darenskaya, E.V. Chugunova, S.I. Kolesnikov, L.A. Grebenkina, N.V. Semenova, O.A. Nikitina, L.I. Kolesnikova
Indicators of endogenous intoxication and lipid peroxidation in the dynamics of treatment with α-lipoic acid in men with diabetic nephropathy at the stage of microalbuminuria
|
38-43 |
|
N. Damyanov, I.B. Vinogradova, A.V. Bezgin, L.A. Knyazeva
A patient with systemic lupus erythematosus and lupus nephritis: the potentials for biological therapy
|
44-48 |
|
I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, Zh.A. Murkamilova, F.A. Yusupov, I.O. Kudaibergenova
Homocystein and folic acid in chronic kidney disease: clinical and predictive significance
|
49-56 |
KIDNEY DISEASES |
|
D.A. Ayypova, A.K. Mukanbaeva, N.A. Beishebaeva, R.R. Kaliev
On the issue of morphological changes in the kidneys when using nasvay
|
57-60 |
|
Z.D. Mikhailova, V.V. Cherepanova
Thrombocytosis as a cause of thrombohemorrhagic complications in the practice of a nephrologiste
|
61-65 |
LITERATURE REVIEWS |
|
I.T. Murkamilov, I.S. Sabirov, V.V. Fomin, Zh.A. Murkamilova, I.O. Kudaibergenova, F.A. Yusupov
Membranose glomerulonephritis in the practice of a therapist
|
66-77 |
|
N.M. Nikitina, V.E. Kharlamov
Urolithiasis as an extra-articular manifestation of ankylosing spondilitis (literature review)
|
78-83 |
|
M.S. Shamkhalova, I.A. Sklyanik, M.V. Shestakova
Beyond glycemic control: nephroprotective effects of glucagon-like peptide 1 receptor agonists
|
84-91 |
LECTURE |
|
A.V. Malinovsky
Discoveries of japanese biochemists that break the traditional understanding of the conversion of threonine and histidine in the human body and the significance of these discoveries in the treatment of uremia
|
92-96 |
Русский
